Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
European Journal of Medical Research
Published in: European Journal of Medical Research 1/2015

Open Access 01-12-2015 | Case report

Acute trophoblastic pulmonary embolism during conservative treatment of placenta accreta: case report and review of literature

Authors: Qiu-ming Wang, Hui-li Liu, Qun Dang

Published in: European Journal of Medical Research | Issue 1/2015

Login to get access

Abstract

Background

Placenta accreta is a rare obstetric condition but can lead to life-threatening complications that was mainly diagnosed in the third trimester. We present a case of acute trophoblastic pulmonary embolism (PE) during conservative treatment of placenta accreta.

Case presentation

A 24-year-old patient who delivered vaginally at 40+4 weeks gestation. The placenta was retained despite the use of oxytocics and attempts of manual removal. Conservative management including uterine arteria embolism, hysteroscopic resection and mifepristone was used but failed and finally the patient died from acute trophoblastic PE and allergic shock when infusing povidone-iodine into her uterine cavity.

Conclusion

Although conservative treatment of placenta accreta can retain reproductive potential and trophoblastic PE is rare, clinicians should consider hysterectomy when conservative treatment failed and infusion of povidone-iodine or other liquid into the cavity should be prohibited.
Literature
1.
Adler E, Madankumar R, Rosner M, et al. Increased placental trophoblast inclusions in placenta accreta[J]. Placenta. 2014;35(12):1075–8.CrossRefPubMed
2.
Sentilhes L, Ambroselli C, Kayem G, et al. Maternal outcome after conservative treatment of placenta accreta[J]. Obstet Gynecol. 2010;115(3):526–34.CrossRefPubMed
3.
Fitzpatrick KE, Sellers S, Spark P, et al. Incidence and risk factors for placenta accreta/increta/percreta in the UK: a national case-control study[J]. PLoS One. 2012;7(12):e52893.PubMedCentralCrossRefPubMed
4.
Ac W, Jm A. Placenta accreta, increta, and percreta.[J]. Obstet Gynecol Clin North Am. 2013;40(1):137–54.CrossRef
5.
Liu Y, Li G, Chen Y, et al. A descriptive analysis of the indications for caesarean section in mainland China[J]. BMC Pregnancy Childbirth. 2014;14(1):410.PubMedCentralCrossRefPubMed
6.
Bauwens J, Coulon C, Azaïs H, et al. Placenta accreta: can prenatal diagnosis be performed? Ultrasound and MRI interests. About 27 cases[J]. Gynecol Obstet Fertil. 2014;42(5):306–11.CrossRefPubMed
7.
Fitzpatrick KE, Sellers S, Spark P, et al. The management and outcomes of placenta accreta, increta, and percreta in the UK: a population-based descriptive study[J]. BJOG Int J Obstet Gynaecol. 2014;121(1):62–71.CrossRef
8.
Gustavo I, César M, Mario G, et al. Feasibility and safety of prophylactic uterine artery catheterization and embolization in the management of placenta accreta.[J]. J Vasc Interv Radiol Jvir. 2015;26:162–9.CrossRef
9.
RoyalCollegeofObstetriciansandGynaecologists.Green-top Guideline No. 27. Placenta praevia, placenta praevia accreta and vasa praevia: diagnosis and management. London: RCOG; 2011.
10.
Morgan M, Atalla R. Mifepristone and misoprostol for the management of placenta accreta–a new alternative approach[J]. BJOG Int J Obstet Gynaecol. 2009;116(7):1002–3.CrossRef
11.
Legendre G, Zoulovits FJ, Kinn J, et al. Conservative management of placenta accreta: hysteroscopic resection of retained tissues[j]. J Minim Invasive Gynecol. 2014;21(5):910–3.CrossRefPubMed
12.
Mueller UW, Hawes CS, Wright AE, et al. Isolation of fetal trophoblast cells from peripheral blood of pregnant women.[J]. Lancet. 1990;336:197–200.CrossRefPubMed
13.
Tews G, Yaman C, Ebner T. Fatal trophoblastic embolism during cesarean section[J]. Int J Gynecol Obstet. 2002;76(2):179–80.CrossRef
14.
Ikarashi T, Takeuchi S, Ohnishi Y. Trophoblastic embolism in sudden maternal death[J]. Nihon Sanka Fujinka Gakkai zasshi. 1988;40(6):793–5.PubMed
15.
Schmorl G. Pathologisch-anatomische Untersuchungen uber Peerperal-Eklampsie. Leipzig: Vogel; 1893.
16.
Garner EI, Chang-Lee WY, Lu KH, et al. Trophoblastic pulmonary embolization after hysterectomy for invasive complete mole. A case report. J Reprod Med. 1999;44:908–12.PubMed
17.
Seiryu K, Yoshiharu O, Osamu M, et al. Placental villotrophoblastic pulmonary emboli. After elective abortion: immunohistochemical diagnosis and comparison with ten control cases[J]. Int J Gynecol Pathol. 2003;22(3):303–9.CrossRef
18.
Jorens PG, Van Marck E, Snoeckx A, et al. Nonthrombotic pulmonary embolism[J]. Eur Respir J. 2009;34(2):452–74.CrossRefPubMed
Metadata
Title
Acute trophoblastic pulmonary embolism during conservative treatment of placenta accreta: case report and review of literature
Authors
Qiu-ming Wang
Hui-li Liu
Qun Dang
Publication date
01-12-2015
Publisher
BioMed Central
Published in
European Journal of Medical Research / Issue 1/2015
Electronic ISSN: 2047-783X
DOI
https://doi.org/10.1186/s40001-015-0185-6

Other articles of this Issue 1/2015

European Journal of Medical Research 1/2015 Go to the issue

Research

Sertoli cell-mediated differentiation of male germ cell-like cells from human umbilical cord Wharton’s jelly-derived mesenchymal stem cells in an in vitro co-culture system

Research

Efficacy and safety of glucosamine, diacerein, and NSAIDs in osteoarthritis knee: a systematic review and network meta-analysis

Research

PALB2 mutations in breast cancer patients from a multi-ethnic region in northwest China

Research

Effects of transforming growth factor β-1 infected human bone marrow mesenchymal stem cells on high- and low-metastatic potential hepatocellular carcinoma

Case report

Fracture of the lesser trochanter as a sign of undiagnosed tumor disease in adults

Reviewer acknowledgement

European Journal of Medical Research reviewer acknowledgment 2014